Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : AIIMS
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.
Product Name : Phytorelief-CC
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 06, 2021
Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : AIIMS
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Verdure Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 22, 2020
Lead Product(s) : Ellagic acid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Verdure Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : University of California, Los Angeles | POM Wonderful
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 20, 2020
Lead Product(s) : Ellagic acid
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : University of California, Los Angeles | POM Wonderful
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : POM Wonderful
Deal Size : Inapplicable
Deal Type : Inapplicable
Reversing Muscle Loss With Exercise Training and Daily Consumption of Pomegranate Juice
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 23, 2017
Lead Product(s) : Ellagic acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : POM Wonderful
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : POM Wonderful
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Pomegranate Juice on Memory in Older Adults
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 20, 2014
Lead Product(s) : Ellagic acid
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : POM Wonderful
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 10, 2012
Lead Product(s) : Ellagic acid
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II
Sponsor : Target Health Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
POMx In the Treatment of Erectile Dysfunction
Details : Undisclosed
Product Name : POMx Extract
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 13, 2010
Lead Product(s) : Ellagic acid
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Sponsor : Target Health Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Pomegranate Extract Biomarker Study in Osteopenic Women
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 13, 2010
Lead Product(s) : Ellagic acid
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ellagic acid
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Lotte & John Hecht Memorial Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of POMELLAâ„¢ Extract to Treat Prostate Cancer
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 09, 2010
Lead Product(s) : Ellagic acid
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Lotte & John Hecht Memorial Foundation
Deal Size : Inapplicable
Deal Type : Inapplicable